PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97401263 |
Filing Date: 05/09/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97401263 |
---|---|
MARK INFORMATION | |
*MARK | ARMOR |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | ARMOR |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | VST LLC |
DBA/AKA/TA/Formerly | DBA Medgene Labs |
*MAILING ADDRESS | 1006 32nd Avenue |
*CITY | Brookings |
*STATE (Required for U.S. applicants) |
South Dakota |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
57006 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | limited liability company |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED | South Dakota |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 001 |
*IDENTIFICATION | Aqueous solution which comprises oils to be used as an adjuvant for vaccine compositions; adjuvant for use in the manufacture of immunology preparations; adjuvant for use in the manufacture of pharmaceutical products and veterinary products; adjuvant for veterinary use; and adjuvant for veterinary applications for use in vaccines |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 02/01/2019 |
FIRST USE IN COMMERCE DATE | At least as early as 08/01/2019 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-26012c5c1003be0b08ea b53bfcbeffc-2022050914142 2478812_._ARMORSPECIMEN.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT 18\974\012\97401263\xml1\ APP0003.JPG |
SPECIMEN DESCRIPTION | Brochure describing use of adjuvant in veterinary vaccines. |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
ATTORNEY INFORMATION | |
NAME | Daryl Basham |
ATTORNEY DOCKET NUMBER | ARMORTMUS |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | SDIP LLC |
STREET | 101 N Main Avenue, Suite 325 |
CITY | Sioux Falls |
STATE | South Dakota |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 57104 |
PHONE | 858-382-4661 |
EMAIL ADDRESS | daryl@southdakotainnovation.com |
OTHER APPOINTED ATTORNEY | Daryl Basham |
RECOGNIZED CANADIAN ATTORNEY/AGENT | Daryl Basham |
CORRESPONDENCE INFORMATION | |
NAME | Daryl Basham |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | daryl@southdakotainnovation.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | sheri@southdakotainnovation.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Daryl A. Basham/ |
SIGNATORY'S NAME | Daryl A. Basham |
SIGNATORY'S POSITION | Chief Legal Officer |
SIGNATORY'S PHONE NUMBER | 858-382-4661 |
DATE SIGNED | 05/09/2022 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97401263 |
Filing Date: 05/09/2022 |
The applicant's current Correspondence Information: |
Daryl Basham |
PRIMARY EMAIL FOR CORRESPONDENCE: daryl@southdakotainnovation.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): sheri@southdakotainnovation.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|